Dynamic changes in expression of myosin phosphatase in a model of portal hypertension. - Wikidata - wikimedia - TriplyDB

Dynamic changes in expression of myosin phosphatase in a model of portal hypertension.

Dynamic changes in expression of myosin phosphatase in a model of portal hypertension.

http://www.wikidata.org/entity/Q44712608

about

Mechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Smooth Muscle Disorders Competition of PTB with TIA proteins for binding to a U-rich cis-element determines tissue-specific splicing of the myosin phosphatase targeting subunit 1 Losartan decreases p42/44 MAPK signaling and preserves LZ+ MYPT1 expression.Increased degradation of MYPT1 contributes to the development of tolerance to nitric oxide in porcine pulmonary artery.A bioinformatic and computational study of myosin phosphatase subunit diversity.Myosin phosphatase isoforms and related transcripts in the pig coronary circulation and effects of exercise and chronic occlusion.Neural programming of mesenteric and renal arteries.Vascular smooth muscle phenotypic diversity and function Role of rho kinase in the functional and dysfunctional tonic smooth muscles.TRA2β controls Mypt1 exon 24 splicing in the developmental maturation of mouse mesenteric artery smooth muscle Regulation of basal LC20 phosphorylation by MYPT1 and CPI-17 in murine gastric antrum, gastric fundus, and proximal colon smooth muscles.Tra2β protein is required for tissue-specific splicing of a smooth muscle myosin phosphatase targeting subunit alternative exon.Redox signaling and splicing dependent change in myosin phosphatase underlie early versus late changes in NO vasodilator reserve in a mouse LPS model of sepsis.Altered Expression of Human Smooth Muscle Myosin Phosphatase Targeting (MYPT) Isovariants with Pregnancy and Labor.Preservation of cGMP-induced relaxation of pulmonary veins of fetal lambs exposed to chronic high altitude hypoxia: role of PKG and Rho kinase.Differential vasodilation of human placental and myometrial arteries related to myofilament Ca(2+)-desensitization and the expression of Hsp20 but not MYPT1.Tra2beta as a novel mediator of vascular smooth muscle diversification.The potential role of MLC phosphatase and MAPK signalling in the pathogenesis of vascular dysfunction in heart failure Smooth muscle contractile diversity in the control of regional circulations.Myosin phosphatase isoforms as determinants of smooth muscle contractile function and calcium sensitivity of force production.Novel contributions of the smoothelin-like 1 protein in vascular smooth muscle contraction and its potential involvement in myogenic tone.MYPT1 protein isoforms are differentially phosphorylated by protein kinase G.MYPT1 isoforms expressed in HEK293T cells are differentially phosphorylated after GTPγS treatment.Altered reactivity of tertiary mesenteric arteries following acute myocardial ischemia.Unique gene program of rat small resistance mesenteric arteries as revealed by deep RNA sequencing.A splice variant of the myosin phosphatase regulatory subunit tunes arterial reactivity and suppresses response to salt loading ROS-mediated downregulation of MYPT1 in smooth muscle cells: a potential mechanism for the aberrant contractility in atherosclerosis.Uterine artery myosin phosphatase isoform switching and increased sensitivity to SNP in a rat L-NAME model of hypertension of pregnancy.Benefit of SERCA2a gene transfer to vascular endothelial and smooth muscle cells: a new aspect in therapy of cardiovascular diseases.Impaired agonist-dependent myosin phosphorylation and decreased RhoA in rat portal hypertensive mesenteric vasculature.Hypoxic pulmonary vasoconstriction

P2860

Q26753129-24C73FF2-8422-4F27-884E-58F76D0813CF Q28565269-D070272C-6AF6-432A-AC39-698AB7229791 Q33428533-56119745-BB05-442C-9A59-64E4C523F62D Q33994665-9C748117-DA63-435A-886E-6214D4EA8ADC Q34001586-ADC2B518-CFCC-4B43-A762-0D1748D54450 Q34051651-6AD52840-0B3E-4680-8620-EC789B20CA35 Q34062825-1A31B663-FB2B-4203-AF3B-26DE339754AF Q34432730-EA47AA7F-18BA-4B59-851B-DF426637DEBC Q35083933-1C0CA552-5BCD-4BFA-AB6A-378BC4C48339 Q35086281-305AE704-B0D6-4E65-B568-4CB32ECCF42C Q35214205-C708DA0F-DDBD-472D-B854-C2710A26C31A Q35956484-51915990-A885-4278-97DF-2D0F51F87E18 Q36000019-58A418BE-1D8F-46AC-B1E8-88971A1A146A Q36178519-56E45A64-3CA4-435C-96DB-560FBF003C11 Q36977280-C76851D2-85BC-4DDE-98CE-0571F60ABA21 Q37272271-42813545-C5D2-4875-90D8-87096702C2B8 Q37332178-6909E64D-333F-46FC-BBA8-E038181A26CE Q37361567-0ABBE86C-F4E5-433E-8185-C51F05D1D5D4 Q37575852-8A6BB905-72BF-4D17-A62A-011F31E93F8D Q38151237-3821BE9B-686B-41EA-86A0-2895C8EB5948 Q38165311-E94B2AD4-D9EC-4A4D-9274-5479D68E0394 Q38795387-E6EA7284-68F5-48B7-9C3E-305E0AF57B42 Q39304331-84CF3B74-FB1C-4D3B-B2D2-B04EA8B07453 Q40301580-EF0B524E-B926-4E6D-86BF-3FE45A996CC2 Q41891029-7E38332A-9A99-4376-B553-730F8DEF7677 Q42109947-8B25DC38-0E24-40FE-BD5E-074E47F04598 Q45113305-2379C033-173E-4863-833C-9A4DF1968D43 Q46840707-200EC971-85C4-4E62-BF06-D13E2B1F551B Q51869172-EA03E2EE-49DE-40CE-A96E-5228126CCB99 Q53881337-D174ADAC-6BA3-4758-86BA-C20988D52F20 Q57099542-D30FE3BC-74CA-471F-85A2-B19635DC4DA9

P2860

Dynamic changes in expression of myosin phosphatase in a model of portal hypertension.

http://www.wikidata.org/entity/Q44712608

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Dynamic changes in expression of myosin phosphatase in a model of portal hypertension.

@en

Dynamic changes in expression of myosin phosphatase in a model of portal hypertension.

@nl

type

label

Dynamic changes in expression of myosin phosphatase in a model of portal hypertension.

@en

Dynamic changes in expression of myosin phosphatase in a model of portal hypertension.

@nl

prefLabel

Dynamic changes in expression of myosin phosphatase in a model of portal hypertension.

@en

Dynamic changes in expression of myosin phosphatase in a model of portal hypertension.

@nl

P1433

Q44712608-01ABC4B4-B605-4B58-AEAC-A98D937128FA

P1476

Q44712608-D698751C-EBCD-434C-BDEC-7E3A0BCD1E75

P2093

Q44712608-4A1A030C-F7B3-45CC-B8B5-4ED266A80B54

Q44712608-5E06FA70-6380-4758-9595-1E8B483388D7

Q44712608-A9744FE7-0255-4086-9397-E6C972A3B773

Q44712608-D36B89A6-A7B2-4661-B132-F87B55326CBB

Q44712608-E0CD7F1B-4B1C-4A60-A6AC-BBDBF6B4223F

Q44712608-EECEC13C-E720-4469-A54E-5DEAB276463D

Q44712608-F3E44F96-BA21-4605-BF25-D21C5DDF8A51

P2860

Q44712608-0E106282-BC12-4DBA-B820-BD3EB34373E2

Q44712608-111F87BE-68B8-4CCB-9752-B9B497BB40CB

Q44712608-11CC5725-53F0-4251-9555-F7E05F209C5E

Q44712608-12E03976-0D9C-4E6B-81AD-35BD00754BBE

Q44712608-2764CF64-5248-41A0-A574-B1AB01E50A69

Q44712608-29AE6938-42BD-44BE-AF79-668D366699F3

Q44712608-347A68C2-46F7-4F9A-AAF5-96D76707C9E8

Q44712608-352FAE93-C7E8-4B06-B6A8-838AB853D033

Q44712608-3E6CC098-5749-4A53-9D3A-35F2B5B06533

Q44712608-45782520-9C2A-4AE0-B4B2-A78BC8D3B52E

P304

Q44712608-4C45627A-A12F-43A5-B645-70C63F40736D

P31

Q44712608-A5C63874-6F2A-44DC-83D8-23BDA8085278

P356

Q44712608-8C13459A-F34A-442B-A3F9-62BBC7BF8963

P433

Q44712608-3C05A0E8-D09B-421D-9659-00FA8E07C1FE

P478

Q44712608-F2F8737C-B1F3-461D-BF16-3FB1A3B27E95

P577

Q44712608-F12E8DB5-4C74-4FC7-8DF4-A19A54035326

P5875

Q44712608-5213E7EB-4551-4C9B-AAFD-7FB2A92ECD80

P698

Q44712608-4D79E4DA-D06E-43D4-9909-B6CC09AAA5DF

P356

AJPHEART.00696.2003

P1433

American Journal of Physiology - Heart and Circulatory Physiology

P1476

Dynamic changes in expression of myosin phosphatase in a model of portal hypertension.

@en

P2093

Hai-Ying Zhang

http://www.w3.org/2001/XMLSchema#string

Joseph N Benoit

http://www.w3.org/2001/XMLSchema#string

Michael C Payne

http://www.w3.org/2001/XMLSchema#string

Mitsuo Ikebe

http://www.w3.org/2001/XMLSchema#string

Steven A Fisher

http://www.w3.org/2001/XMLSchema#string

Yasuhiko Koga

http://www.w3.org/2001/XMLSchema#string

Yuichi Shirasawa

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase)

Regulation of myosin phosphatase by a specific interaction with cGMP- dependent protein kinase Ialpha

Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca2+ sensitization of contraction in vascular smooth muscle

Signal-dependent regulation of splicing via phosphorylation of Sam68

Myosin light chain phosphatase: subunit composition, interactions and regulation

SRPK1 and Clk/Sty protein kinases show distinct substrate specificities for serine/arginine-rich splicing factors

Loss of SM-B myosin affects muscle shortening velocity and maximal force development

Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase

Smooth muscle myosin phosphatase-associated kinase induces Ca2+ sensitization via myosin phosphatase inhibition.

Coronary microcirculation in health and disease. Summary of an NHLBI workshop.

P304

H1801-10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPHEART.00696.2003

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

286

http://www.w3.org/2001/XMLSchema#string

P577

2004-01-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8935992

http://www.w3.org/2001/XMLSchema#string

P698

14704233

http://www.w3.org/2001/XMLSchema#string